Termination of drug-induced torsades de pointes with overdrive pacing

American Journal of Emergency Medicine

Volumn 28, Issue 1, 2010, Pages 95-102

  Charlton, Nathan P ^a   Lawrence, David T ^a   Brady, William J ^a   Kirk, Mark A ^a   Holstege, Christopher P ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CLONAZEPAM; DIPHENHYDRAMINE; GLUCAGON; GLUCONATE CALCIUM; ISOPRENALINE; LITHIUM; MAGNESIUM SULFATE; OLANZAPINE; SOTALOL; ZIPRASIDONE;

ADULT; ALCOHOL INTOXICATION; ARTICLE; ASPIRATION PNEUMONIA; ASSISTED VENTILATION; CASE REPORT; DRUG OVERDOSE; ELECTROCARDIOGRAPHY; FEMALE; HEART PACING; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; PACEMAKER; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; SEIZURE; SINUS BRADYCARDIA; SINUS TACHYCARDIA; TORSADE DES POINTES; VITAL SIGN;

ADULT; CARDIAC PACING, ARTIFICIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; OVERDOSE; TORSADES DE POINTES;

EID: 71649108872     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2008.09.029     Document Type: Article

References (20)

1. Viskin S., Justo D., Halkin A., and Zeltser D. Long QT syndrome caused by noncardiac drugs. Prog Cardiovasc Dis 45 5 (2003) 415-427
2. Kao L.W., and Furbee R.B. Drug-induced Q-T prolongation. Med Clin North Am 89 6 (2005) 1125-1144
3. Yap Y.G., and Camm A.J. Drug induced QT prolongation and torsades de pointes. Heart 89 11 (2003) 1363-1372
4. Gowda R.M., Khan I.A., Wilbur S.L., Vasavada B.C., and Sacchi T.J. Torsade de pointes: the clinical considerations. Inter J Cardiol 96 1 (2004) 1-6
5. Liu J., and Laurita K.R. The mechanism of pause-induced torsade de pointes in long QT syndrome. J Cardiovasc Electrophysiol 16 9 (2005) 981-987
6. Thomsen M.B., Volders P.G., Beekman J.D., Matz J., and Vos M.A. Beat-to-beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes. J Amer Coll Cardiol 48 6 (2006) 1268-1276
7. Sadanaga T., Sadanaga F., Yao H., and Fujishima M. An evaluation of ECG leads used to assess QT prolongation. Cardiol 105 3 (2006) 149-154
8. Gupta A., Lawrence A.T., Krishnan K., Kavinsky C.J., and Trohman R.G. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart Jour 153 6 (2007) 891-899
9. Chan A., Isbister G.K., Kirkpatrick C.M., and Dufful S.B. Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. QJM 100 10 (2007) 609-615
10. Khan I.A., and Gowda R.M. Novel therapeutics for treatment of long-QT syndrome and torsade de pointes. Int J Cardiol 95 1 (2004) 1-6
11. Chiang C.E. Congenital and acquired long QT syndrome: current concepts and management. Cardiol Rev 12 4 (2004) 222-234
12. Viskin S. Long QT syndromes and torsade de pointes. Lancet 354 9190 (1999) 1625-1633
13. Mancuso E.M., Brady W.J., Harrigan R.A., Pollack M., and Chan T. Electrocardiographic manifestations: long QT Syndrome. J Emerg Med 27 4 (2004) 385-393
14. Roden D.M. Cellular basis of drug-induced torsades de pointes. Br J Pharmacol 154 7 (2008) 1502-1507
15. Tzivoni D., Keren A., Cohen A.M., Loebel H., Zahavi I., Chenzbraun A., et al. Magnesium therapy for torsades de pointes. Am J of Cardiol 53 4 (1984) 528-530
16. Prielipp R.C., Butterworth J.F., Roberts P.R., Black K.W., and Zaloga G.P. Magnesium antagonizes the actions of lysophosphatidyl choline (LPC) in myocardial cells: a possible mechanism for its antiarrhythmic effects. Anesth Analg 80 6 (1995) 1083-1087
17. Iseri L.T., Allen B.J., Ginkel M.L., and Brodsky M.A. Ionic biology and ionic medicine in cardiac arrhythmias with particular reference to magnesium. Am Heart J 123 5 (1992) 1404-1409
18. Tzivoni D., Banai S., Schuger C., Benhorin J., Keren A., Gottlieb S., et al. Treatment of torsade de pointes with magnesium sulfate. Circulation 77 2 (1988) 392-397
19. Anonymous. Part 12: pediatric advanced life support. Circulation 112 24 (2005) 167-187
20. Hoshino K., Ogawa K., Hishitani T., Isobe T., and Eto Y. Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome. Pediatr Int 48 2 (2006) 112-117